CIM Investment Management’s Lifestance Health LFST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-11,895
Closed -$83.7K 260
2025
Q4
$83.7K Hold
11,895
0.02% 237
2025
Q3
$65.4K Sell
11,895
-12,839
-52% -$62.9K 0.02% 242
2025
Q2
$156K Buy
24,734
+12,414
+101% +$74.4K 0.03% 246
2025
Q1
$82.1K Sell
12,320
-302
-2% -$2.3K 0.02% 231
2024
Q4
$93K Hold
12,622
0.03% 240
2024
Q3
$88.4K Hold
12,622
0.03% 247
2024
Q2
$62K Sell
12,622
-3,086
-20% -$18.6K 0.02% 248
2024
Q1
$96.9K Hold
15,708
0.03% 276
2023
Q4
$123K Hold
15,708
0.04% 276
2023
Q3
$108K Hold
15,708
0.04% 268
2023
Q2
$143K Sell
15,708
-15,713
-50% -$131K 0.05% 262
2023
Q1
$233K Buy
+31,421
New +$174K 0.09% 223

Other funds holding LFST

CIM Investment Management's LFST Position: Q1 2026 in Review

CIM Investment Management sold out of Lifestance Health (LFST) in Q1 2026, closing a stake of 11,895 shares — an estimated $83.7K sold.

CIM Investment Management first reported a position in LFST in Q1 2023 and held it in 12 quarters. The position peaked at $233K in Q1 2023. 229 funds tracked by Wall St. Rank hold LFST as of Q1 2026.

  • CIM Investment Management reported no remaining Lifestance Health position as of Q1 2026 after selling out during the quarter.
  • CIM Investment Management sold 11,895 Lifestance Health shares in Q1 2026, an estimated $83.7K.
  • CIM Investment Management first reported a position in Lifestance Health in Q1 2023 and held it in 12 quarters.
  • CIM Investment Management's Lifestance Health position peaked at $233K in Q1 2023.
  • 229 funds tracked by Wall St. Rank held Lifestance Health as of Q1 2026.

Based on CIM Investment Management's 13F filing for Q1 2026, filed 19 May 2026.